SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Panagos Constantinos

(Last)

(First)

(Middle)

C/O IQVIA HOLDINGS INC.

4820 EMPEROR BLVD.

(Street)

DURHAM

27703

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/17/2022

3. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	37,219⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Appreciation Right	02/08/2021	02/08/2028	Common Stock	2,853	$95.23	D
Stock Appreciation Right	02/13/2022	02/13/2029	Common Stock	7,681	$131.82	D
Stock Appreciation Right	⁽²⁾	02/11/2030	Common Stock	11,202	$161.7	D
Stock Appreciation Right	⁽³⁾	02/09/2031	Common Stock	6,675	$183.82	D
Stock Appreciation Right	⁽⁴⁾	02/10/2032	Common Stock	7,283	$250.43	D

Explanation of Responses:

1. This amount includes 4,090 RSUs granted on November 1, 2018 which will vest on November 1, 2022, 6,253 RSUs granted on February 11, 2020 which will vest in two annual installments beginning on February 11, 2023, 1,114 RSUs granted on February 9, 2021 which will vest in two annual installments beginning on February 9, 2023, 10,700 RSUs granted on February 9, 2021 which will vest in two annual installments beginning on February 9, 2023, 1,956 RSUs granted on February 10, 2022 which will vest in three annual installments beginning on February 10, 2023 and 3,912 RSUs granted on February 10, 2022 which will vest in two annual installments beginning on February 10, 2024.

2. This stock appreciation right remains outstanding under the grant; 7,468 of which are currently vested; and 3,734 of which will vest on February 11, 2023.

3. This stock appreciation right remains outstanding under the grant; 2,225 of which are currently vested; and 4,450 of which will vest in two annual installments beginning on February 9, 2023.

4. This stock appreciation right vests in three annual installments beginning on February 10, 2023.

Remarks:

President, Research & Development Solutions Power of Attorney

	/s/ Matthew Gilmartin, Attorney-in-Fact for Constantinos Panagos	03/17/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.